Cardoneanu, A.; Burlui, A.M.; Macovei, L.A.; Bratoiu, I.; Richter, P.; Rezus, E.
Targeting Systemic Sclerosis from Pathogenic Mechanisms to Clinical Manifestations: Why IL-6? Biomedicines 2022, 10, 318.
https://doi.org/10.3390/biomedicines10020318
AMA Style
Cardoneanu A, Burlui AM, Macovei LA, Bratoiu I, Richter P, Rezus E.
Targeting Systemic Sclerosis from Pathogenic Mechanisms to Clinical Manifestations: Why IL-6? Biomedicines. 2022; 10(2):318.
https://doi.org/10.3390/biomedicines10020318
Chicago/Turabian Style
Cardoneanu, Anca, Alexandra Maria Burlui, Luana Andreea Macovei, Ioana Bratoiu, Patricia Richter, and Elena Rezus.
2022. "Targeting Systemic Sclerosis from Pathogenic Mechanisms to Clinical Manifestations: Why IL-6?" Biomedicines 10, no. 2: 318.
https://doi.org/10.3390/biomedicines10020318
APA Style
Cardoneanu, A., Burlui, A. M., Macovei, L. A., Bratoiu, I., Richter, P., & Rezus, E.
(2022). Targeting Systemic Sclerosis from Pathogenic Mechanisms to Clinical Manifestations: Why IL-6? Biomedicines, 10(2), 318.
https://doi.org/10.3390/biomedicines10020318